TuHURA Biosciences, Inc.  ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today reported financial results for the Company's ...

BioCardia, Inc. ( NASDAQ: BCDA) Q1 2025 Earnings Conference Call May 14, 2025, 16:30 PM ET Peter Altman - President and CEO David McClung - CFO Miranda Peto - IR Joe Pantginis - H.C. Wainwright Laura ...

Q1 2025 Earnings Call Transcript May 13, 2025 Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Casandra Ventura, who has testified that Mr. Combs was physically abusive and coerced her into marathon sex sessions, will be ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

IND filing and initial clinical data on first targeted Radio-DARPin therapy program, MP0712, expected in 2025; strategic partnership with Orano Med expanded from four to ten programs "Molecular ...

In a term that was increasingly overshadowed by emergency requests related to President Trump’s swift executive actions, ...

Al Horford couldn't be any prouder of Luke Kornet and Jaylen Brown after they powered the Celtics to a crucial Game 5 win.

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive ...

This article will be updated weekly with the status of key bills, including new ‘Deep Dives’ and priority designations, as ...

Lawmakers resolved some years-long disputes between the Iowa House and Senate, as well as approving major segments of the state budget, before adjourning the legislative session early Thursday. One ...

PRESS RELEASEAB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros as of ...